Seiji Mabuchi

14PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsEpidemiological modellingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 13, 2026
Mirvetuximab soravtansine in platinum-resistant ovarian cancer: from biological rationale to clinical impact and future directions.

|Sep 26, 2025
The activity of immune checkpoint inhibitors in patients with recurrent cervical cancer developed in previously irradiated field: clinical and immunohistochemical investigations.

Seiji Mabuchi, Naoko Komura, Harumi Nakamura

|Dec 04, 2024
Robotic salvage radical hysterectomy for locally recurrent cervical cancer: A comparison with open surgery in a single-surgeon series.

Seiji Mabuchi, Michihide Maeda, Mina Sakata

|May 19, 2024
Trends in incidence and hormonal management of endometrial cancer during potentially reproductive age in Japan: a population-based study.

Tomoyuki Sasano, Seiji Mabuchi, Naoko Komura

|Jun 27, 2023
Evaluation of survival outcomes between minimally invasive and open surgery in the treatment of early-stage endometrial cancer: a population-based study in Osaka Japan.

Tomoyuki Sasano, Seiji Mabuchi, Naoko Komura

|Nov 17, 2022
Impact of lymphadenectomy in patients with locally recurrent or persistent cervical cancer treated with salvage hysterectomy.

Seiji Mabuchi, Naoko Komura, Michiko Kodama

Pageof 3

Frequent Collaborators

3 joint publications

Tadashi Kimura

2 joint publications

Yuri Matsumoto

2 joint publications

Naoko Komura

1 joint publications

Toru Sugiyama